Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT04571372
Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor in Valvular Heart Disease
Sponsor: Yonsei University
View on ClinicalTrials.gov
Summary
This study investigates the association between level of suPAR and valvular heart disease in patients who have severe aortic stenosis or severe aortic regurgitation using commercially available suPARnostic standard enzyme-linked immunosorbent assay (ViroGates, Denmark)
Key Details
Gender
All
Age Range
19 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
222
Start Date
2020-08-14
Completion Date
2025-12-13
Last Updated
2026-07-13
Healthy Volunteers
No
Locations (1)
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine
Seoul, South Korea